#BREAKING: FDA approves a clinical trial that will allow Johns Hopkins researchers to test a therapy for #COVID19 & find out whether plasma is effective in protecting healthcare workers & first responders from the virus. More on @wjz at 7 & 11...

— Rick Ritter (@RickRitterWJZ) April 3, 2020